naringenin has been researched along with galactose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, G; Liu, B; Tan, LY; Zhang, LH; Zhang, N; Zhang, Y | 1 |
| Ahmad, S; Batool, Z; Haider, S; Liaquat, L; Naz, N; Rafiq, S; Shahzad, S; Siddiqui, RA; Tabassum, S | 1 |
2 other study(ies) available for naringenin and galactose
| Article | Year |
|---|---|
Naringenin Ameliorates Behavioral Dysfunction and Neurological Deficits in a d-Galactose-Induced Aging Mouse Model Through Activation of PI3K/Akt/Nrf2 Pathway.
Topics: Aging; Animals; Apoptosis; Behavior, Animal; Body Weight; Brain; Disease Models, Animal; Flavanones; Galactose; Male; Memory; Mice, Inbred ICR; Motor Activity; Neurons; NF-E2-Related Factor 2; Organ Size; Oxidation-Reduction; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Spatial Learning | 2017 |
Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress.
Topics: Acetylcholinesterase; Aluminum Chloride; Alzheimer Disease; Animals; Antioxidants; Brain; Cognition; Disease Models, Animal; Executive Function; Flavanones; Galactose; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats, Wistar | 2020 |